Global Opioid-Induced Constipation Sales Market Report 2021

Global Opioid-Induced Constipation Sales Market Report 2021

Table of Contents
1 Opioid-Induced Constipation Market Overview
1.1 Opioid-Induced Constipation Product Scope
1.2 Opioid-Induced Constipation Segment by Type
1.2.1 Global Opioid-Induced Constipation Sales by Type (2016 & 2021 & 2027)
1.2.2 Methylnaltrexone Bromide
1.2.3 Lubiprostone
1.2.4 Naloxegol
1.2.5 Others
1.3 Opioid-Induced Constipation Segment by Application
1.3.1 Global Opioid-Induced Constipation Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Opioid-Induced Constipation Market Estimates and Forecasts (2016-2027)
1.4.1 Global Opioid-Induced Constipation Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Opioid-Induced Constipation Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Opioid-Induced Constipation Price Trends (2016-2027)
2 Opioid-Induced Constipation Estimates and Forecasts by Region
2.1 Global Opioid-Induced Constipation Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Opioid-Induced Constipation Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Opioid-Induced Constipation Sales Market Share by Region (2016-2021)
2.2.2 Global Opioid-Induced Constipation Revenue Market Share by Region (2016-2021)
2.3 Global Opioid-Induced Constipation Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Opioid-Induced Constipation Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Opioid-Induced Constipation Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.2 Europe Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.3 China Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.4 Japan Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.6 India Opioid-Induced Constipation Estimates and Projections (2016-2027)
3 Global Opioid-Induced Constipation Competition Landscape by Players
3.1 Global Top Opioid-Induced Constipation Players by Sales (2016-2021)
3.2 Global Top Opioid-Induced Constipation Players by Revenue (2016-2021)
3.3 Global Opioid-Induced Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid-Induced Constipation as of 2020)
3.4 Global Opioid-Induced Constipation Average Price by Company (2016-2021)
3.5 Manufacturers Opioid-Induced Constipation Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Opioid-Induced Constipation Market Size by Type
4.1 Global Opioid-Induced Constipation Historic Market Review by Type (2016-2021)
4.1.1 Global Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
4.1.2 Global Opioid-Induced Constipation Revenue Market Share by Type (2016-2021)
4.1.3 Global Opioid-Induced Constipation Price by Type (2016-2021)
4.2 Global Opioid-Induced Constipation Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Opioid-Induced Constipation Sales Forecast by Type (2022-2027)
4.2.2 Global Opioid-Induced Constipation Revenue Forecast by Type (2022-2027)
4.2.3 Global Opioid-Induced Constipation Price Forecast by Type (2022-2027)
5 Global Opioid-Induced Constipation Market Size by Application
5.1 Global Opioid-Induced Constipation Historic Market Review by Application (2016-2021)
5.1.1 Global Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
5.1.2 Global Opioid-Induced Constipation Revenue Market Share by Application (2016-2021)
5.1.3 Global Opioid-Induced Constipation Price by Application (2016-2021)
5.2 Global Opioid-Induced Constipation Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Opioid-Induced Constipation Sales Forecast by Application (2022-2027)
5.2.2 Global Opioid-Induced Constipation Revenue Forecast by Application (2022-2027)
5.2.3 Global Opioid-Induced Constipation Price Forecast by Application (2022-2027)
6 North America Opioid-Induced Constipation Market Facts & Figures
6.1 North America Opioid-Induced Constipation Sales by Company
6.1.1 North America Opioid-Induced Constipation Sales by Company (2016-2021)
6.1.2 North America Opioid-Induced Constipation Revenue by Company (2016-2021)
6.2 North America Opioid-Induced Constipation Sales Breakdown by Type
6.2.1 North America Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
6.2.2 North America Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
6.3 North America Opioid-Induced Constipation Sales Breakdown by Application
6.3.1 North America Opioid-Induced Constipation Sales Breakdown by Application (2016-2021)
6.3.2 North America Opioid-Induced Constipation Sales Breakdown by Application (2022-2027)
7 Europe Opioid-Induced Constipation Market Facts & Figures
7.1 Europe Opioid-Induced Constipation Sales by Company
7.1.1 Europe Opioid-Induced Constipation Sales by Company (2016-2021)
7.1.2 Europe Opioid-Induced Constipation Revenue by Company (2016-2021)
7.2 Europe Opioid-Induced Constipation Sales Breakdown by Type
7.2.1 Europe Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
7.2.2 Europe Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
7.3 Europe Opioid-Induced Constipation Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Opioid-Induced Constipation Market Facts & Figures
8.1 China Opioid-Induced Constipation Sales by Company
8.1.1 China Opioid-Induced Constipation Sales by Company (2016-2021)
8.1.2 China Opioid-Induced Constipation Revenue by Company (2016-2021)
8.2 China Opioid-Induced Constipation Sales Breakdown by Type
8.2.1 China Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
8.2.2 China Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
8.3 China Opioid-Induced Constipation Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Opioid-Induced Constipation Market Facts & Figures
9.1 Japan Opioid-Induced Constipation Sales by Company
9.1.1 Japan Opioid-Induced Constipation Sales by Company (2016-2021)
9.1.2 Japan Opioid-Induced Constipation Revenue by Company (2016-2021)
9.2 Japan Opioid-Induced Constipation Sales Breakdown by Type
9.2.1 Japan Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
9.2.2 Japan Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
9.3 Japan Opioid-Induced Constipation Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Opioid-Induced Constipation Market Facts & Figures
10.1 Southeast Asia Opioid-Induced Constipation Sales by Company
10.1.1 Southeast Asia Opioid-Induced Constipation Sales by Company (2016-2021)
10.1.2 Southeast Asia Opioid-Induced Constipation Revenue by Company (2016-2021)
10.2 Southeast Asia Opioid-Induced Constipation Sales Breakdown by Type
10.2.1 Southeast Asia Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Opioid-Induced Constipation Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Opioid-Induced Constipation Market Facts & Figures
11.1 India Opioid-Induced Constipation Sales by Company
11.1.1 India Opioid-Induced Constipation Sales by Company (2016-2021)
11.1.2 India Opioid-Induced Constipation Revenue by Company (2016-2021)
11.2 India Opioid-Induced Constipation Sales Breakdown by Type
11.2.1 India Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
11.2.2 India Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
11.3 India Opioid-Induced Constipation Sales Breakdown by Application
11.3.1 India Opioid-Induced Constipation Sales Breakdown by Application (2016-2021)
11.3.2 India Opioid-Induced Constipation Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Opioid-Induced Constipation Business
12.1 Takeda Pharmaceuticals
12.1.1 Takeda Pharmaceuticals Corporation Information
12.1.2 Takeda Pharmaceuticals Business Overview
12.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Takeda Pharmaceuticals Opioid-Induced Constipation Products Offered
12.1.5 Takeda Pharmaceuticals Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Opioid-Induced Constipation Products Offered
12.2.5 Bayer Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Opioid-Induced Constipation Products Offered
12.3.5 Sanofi Recent Development
12.4 Mallinckrodt
12.4.1 Mallinckrodt Corporation Information
12.4.2 Mallinckrodt Business Overview
12.4.3 Mallinckrodt Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mallinckrodt Opioid-Induced Constipation Products Offered
12.4.5 Mallinckrodt Recent Development
12.5 Salix (Bausch Health)
12.5.1 Salix (Bausch Health) Corporation Information
12.5.2 Salix (Bausch Health) Business Overview
12.5.3 Salix (Bausch Health) Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Salix (Bausch Health) Opioid-Induced Constipation Products Offered
12.5.5 Salix (Bausch Health) Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Business Overview
12.6.3 AstraZeneca Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AstraZeneca Opioid-Induced Constipation Products Offered
12.6.5 AstraZeneca Recent Development
12.7 Progenics Pharmaceuticals
12.7.1 Progenics Pharmaceuticals Corporation Information
12.7.2 Progenics Pharmaceuticals Business Overview
12.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Progenics Pharmaceuticals Opioid-Induced Constipation Products Offered
12.7.5 Progenics Pharmaceuticals Recent Development
12.8 Purdue Pharm
12.8.1 Purdue Pharm Corporation Information
12.8.2 Purdue Pharm Business Overview
12.8.3 Purdue Pharm Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Purdue Pharm Opioid-Induced Constipation Products Offered
12.8.5 Purdue Pharm Recent Development
12.9 Nektar Therapeutics
12.9.1 Nektar Therapeutics Corporation Information
12.9.2 Nektar Therapeutics Business Overview
12.9.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Nektar Therapeutics Opioid-Induced Constipation Products Offered
12.9.5 Nektar Therapeutics Recent Development
12.10 Daiichi Sankyo
12.10.1 Daiichi Sankyo Corporation Information
12.10.2 Daiichi Sankyo Business Overview
12.10.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Daiichi Sankyo Opioid-Induced Constipation Products Offered
12.10.5 Daiichi Sankyo Recent Development
12.11 Prestige
12.11.1 Prestige Corporation Information
12.11.2 Prestige Business Overview
12.11.3 Prestige Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Prestige Opioid-Induced Constipation Products Offered
12.11.5 Prestige Recent Development
12.12 GSK
12.12.1 GSK Corporation Information
12.12.2 GSK Business Overview
12.12.3 GSK Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.12.4 GSK Opioid-Induced Constipation Products Offered
12.12.5 GSK Recent Development
12.13 Shionogi
12.13.1 Shionogi Corporation Information
12.13.2 Shionogi Business Overview
12.13.3 Shionogi Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shionogi Opioid-Induced Constipation Products Offered
12.13.5 Shionogi Recent Development
13 Opioid-Induced Constipation Manufacturing Cost Analysis
13.1 Opioid-Induced Constipation Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioid-Induced Constipation
13.4 Opioid-Induced Constipation Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioid-Induced Constipation Distributors List
14.3 Opioid-Induced Constipation Customers
15 Market Dynamics
15.1 Opioid-Induced Constipation Market Trends
15.2 Opioid-Induced Constipation Drivers
15.3 Opioid-Induced Constipation Market Challenges
15.4 Opioid-Induced Constipation Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Opioid-Induced Constipation Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Opioid-Induced Constipation Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Opioid-Induced Constipation Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Opioid-Induced Constipation Sales (K Units) by Region (2016-2021)
Table 5. Global Opioid-Induced Constipation Sales Market Share by Region (2016-2021)
Table 6. Global Opioid-Induced Constipation Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Opioid-Induced Constipation Revenue Share by Region (2016-2021)
Table 8. Global Opioid-Induced Constipation Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Opioid-Induced Constipation Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Opioid-Induced Constipation Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Opioid-Induced Constipation Revenue Share Forecast by Region (2022-2027)
Table 12. Global Opioid-Induced Constipation Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Opioid-Induced Constipation Sales Share by Company (2016-2021)
Table 14. Global Opioid-Induced Constipation Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Opioid-Induced Constipation Revenue Share by Company (2016-2021)
Table 16. Global Opioid-Induced Constipation by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation as of 2020)
Table 17. Global Opioid-Induced Constipation Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Opioid-Induced Constipation Manufacturing Sites and Area Served
Table 19. Manufacturers Opioid-Induced Constipation Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Opioid-Induced Constipation Sales (K Units) by Type (2016-2021)
Table 22. Global Opioid-Induced Constipation Sales Share by Type (2016-2021)
Table 23. Global Opioid-Induced Constipation Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Opioid-Induced Constipation Price (USD/Unit) by Type (2016-2021)
Table 25. Global Opioid-Induced Constipation Sales Share by Type (2022-2027)
Table 26. Global Opioid-Induced Constipation Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Opioid-Induced Constipation Revenue Share by Type (2022-2027)
Table 28. Global Opioid-Induced Constipation Price (USD/Unit) by Type (2022-2027)
Table 29. Global Opioid-Induced Constipation Sales (K Units) by Application (2016-2021)
Table 30. Global Opioid-Induced Constipation Sales Share by Application (2016-2021)
Table 31. Global Opioid-Induced Constipation Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Opioid-Induced Constipation Price (USD/Unit) by Application (2016-2021)
Table 33. Global Opioid-Induced Constipation Sales (K Units) by Application (2022-2027)
Table 34. Global Opioid-Induced Constipation Sales Share by Application (2022-2027)
Table 35. Global Opioid-Induced Constipation Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Opioid-Induced Constipation Revenue Share by Application (2022-2027)
Table 37. Global Opioid-Induced Constipation Price (USD/Unit) by Application (2022-2027)
Table 38. North America Opioid-Induced Constipation Sales (K Units) by Company (2016-2021)
Table 39. North America Opioid-Induced Constipation Sales Market Share by Company (2016-2021)
Table 40. North America Opioid-Induced Constipation Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Opioid-Induced Constipation Revenue Market Share by Company (2016-2021)
Table 42. North America Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 43. North America Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 44. North America Opioid-Induced Constipation Sales by Type (2022-2027) & (K Units)
Table 45. North America Opioid-Induced Constipation Sales Market Share by Type (2022-2027)
Table 46. North America Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 47. North America Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 48. North America Opioid-Induced Constipation Sales by Application (2022-2027) & (K Units)
Table 49. North America Opioid-Induced Constipation Sales Market Share by Application (2022-2027)
Table 50. Europe Opioid-Induced Constipation Sales (K Units) by Company (2016-2021)
Table 51. Europe Opioid-Induced Constipation Sales Market Share by Company (2016-2021)
Table 52. Europe Opioid-Induced Constipation Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Opioid-Induced Constipation Revenue Market Share by Company (2016-2021)
Table 54. Europe Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 55. Europe Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 56. Europe Opioid-Induced Constipation Sales by Type (2022-2027) & (K Units)
Table 57. Europe Opioid-Induced Constipation Sales Market Share by Type (2022-2027)
Table 58. Europe Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 59. Europe Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 60. Europe Opioid-Induced Constipation Sales by Application (2022-2027) & (K Units)
Table 61. Europe Opioid-Induced Constipation Sales Market Share by Application (2022-2027)
Table 62. China Opioid-Induced Constipation Sales (K Units) by Company (2016-2021)
Table 63. China Opioid-Induced Constipation Sales Market Share by Company (2016-2021)
Table 64. China Opioid-Induced Constipation Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Opioid-Induced Constipation Revenue Market Share by Company (2016-2021)
Table 66. China Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 67. China Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 68. China Opioid-Induced Constipation Sales by Type (2022-2027) & (K Units)
Table 69. China Opioid-Induced Constipation Sales Market Share by Type (2022-2027)
Table 70. China Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 71. China Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 72. China Opioid-Induced Constipation Sales by Application (2022-2027) & (K Units)
Table 73. China Opioid-Induced Constipation Sales Market Share by Application (2022-2027)
Table 74. Japan Opioid-Induced Constipation Sales (K Units) by Company (2016-2021)
Table 75. Japan Opioid-Induced Constipation Sales Market Share by Company (2016-2021)
Table 76. Japan Opioid-Induced Constipation Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Opioid-Induced Constipation Revenue Market Share by Company (2016-2021)
Table 78. Japan Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 79. Japan Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 80. Japan Opioid-Induced Constipation Sales by Type (2022-2027) & (K Units)
Table 81. Japan Opioid-Induced Constipation Sales Market Share by Type (2022-2027)
Table 82. Japan Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 83. Japan Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 84. Japan Opioid-Induced Constipation Sales by Application (2022-2027) & (K Units)
Table 85. Japan Opioid-Induced Constipation Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Opioid-Induced Constipation Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Opioid-Induced Constipation Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Opioid-Induced Constipation Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Opioid-Induced Constipation Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Opioid-Induced Constipation Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Opioid-Induced Constipation Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Opioid-Induced Constipation Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Opioid-Induced Constipation Sales Market Share by Application (2022-2027)
Table 98. India Opioid-Induced Constipation Sales (K Units) by Company (2016-2021)
Table 99. India Opioid-Induced Constipation Sales Market Share by Company (2016-2021)
Table 100. India Opioid-Induced Constipation Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Opioid-Induced Constipation Revenue Market Share by Company (2016-2021)
Table 102. India Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 103. India Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 104. India Opioid-Induced Constipation Sales by Type (2022-2027) & (K Units)
Table 105. India Opioid-Induced Constipation Sales Market Share by Type (2022-2027)
Table 106. India Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 107. India Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 108. India Opioid-Induced Constipation Sales by Application (2022-2027) & (K Units)
Table 109. India Opioid-Induced Constipation Sales Market Share by Application (2022-2027)
Table 110. Takeda Pharmaceuticals Corporation Information
Table 111. Takeda Pharmaceuticals Description and Business Overview
Table 112. Takeda Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Takeda Pharmaceuticals Opioid-Induced Constipation Product
Table 114. Takeda Pharmaceuticals Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Bayer Opioid-Induced Constipation Product
Table 119. Bayer Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Sanofi Opioid-Induced Constipation Product
Table 124. Sanofi Recent Development
Table 125. Mallinckrodt Corporation Information
Table 126. Mallinckrodt Description and Business Overview
Table 127. Mallinckrodt Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Mallinckrodt Opioid-Induced Constipation Product
Table 129. Mallinckrodt Recent Development
Table 130. Salix (Bausch Health) Corporation Information
Table 131. Salix (Bausch Health) Description and Business Overview
Table 132. Salix (Bausch Health) Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Salix (Bausch Health) Opioid-Induced Constipation Product
Table 134. Salix (Bausch Health) Recent Development
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. AstraZeneca Opioid-Induced Constipation Product
Table 139. AstraZeneca Recent Development
Table 140. Progenics Pharmaceuticals Corporation Information
Table 141. Progenics Pharmaceuticals Description and Business Overview
Table 142. Progenics Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Progenics Pharmaceuticals Opioid-Induced Constipation Product
Table 144. Progenics Pharmaceuticals Recent Development
Table 145. Purdue Pharm Corporation Information
Table 146. Purdue Pharm Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Purdue Pharm Description and Business Overview
Table 148. Purdue Pharm Opioid-Induced Constipation Product
Table 149. Purdue Pharm Recent Development
Table 150. Nektar Therapeutics Corporation Information
Table 151. Nektar Therapeutics Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Nektar Therapeutics Description and Business Overview
Table 153. Nektar Therapeutics Opioid-Induced Constipation Product
Table 154. Nektar Therapeutics Recent Development
Table 155. Daiichi Sankyo Corporation Information
Table 156. Daiichi Sankyo Description and Business Overview
Table 157. Daiichi Sankyo Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Daiichi Sankyo Opioid-Induced Constipation Product
Table 159. Daiichi Sankyo Recent Development
Table 160. Prestige Corporation Information
Table 161. Prestige Description and Business Overview
Table 162. Prestige Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Prestige Opioid-Induced Constipation Product
Table 164. Prestige Recent Development
Table 165. GSK Corporation Information
Table 166. GSK Description and Business Overview
Table 167. GSK Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. GSK Opioid-Induced Constipation Product
Table 169. GSK Recent Development
Table 170. Shionogi Corporation Information
Table 171. Shionogi Description and Business Overview
Table 172. Shionogi Opioid-Induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Shionogi Opioid-Induced Constipation Product
Table 174. Shionogi Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Opioid-Induced Constipation Distributors List
Table 178. Opioid-Induced Constipation Customers List
Table 179. Opioid-Induced Constipation Market Trends
Table 180. Opioid-Induced Constipation Market Drivers
Table 181. Opioid-Induced Constipation Market Challenges
Table 182. Opioid-Induced Constipation Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioid-Induced Constipation Product Picture
Figure 2. Global Opioid-Induced Constipation Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Opioid-Induced Constipation Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Global Opioid-Induced Constipation Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Opioid-Induced Constipation Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Opioid-Induced Constipation Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Opioid-Induced Constipation Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Opioid-Induced Constipation Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Opioid-Induced Constipation Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Opioid-Induced Constipation Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Opioid-Induced Constipation Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Opioid-Induced Constipation Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Opioid-Induced Constipation Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Opioid-Induced Constipation Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Opioid-Induced Constipation Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Opioid-Induced Constipation Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Opioid-Induced Constipation Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Opioid-Induced Constipation Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Opioid-Induced Constipation Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Opioid-Induced Constipation R

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs